1.020USDMkt Cap: 273.62M USDP/E: —Last update: 2026-05-21
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. Its product portfolio includes Vafseo (vadadustat), an oral hypo…
Industry Peers
Drug Manufacturers - Specialty & Generic153.14BSEKP/E 168.3
54.96BEURP/E 21.7
52.53BTRYP/E 27.3
33.63BPLNP/E 21.9
13.36BSEKP/E 40.3
13.24BEURP/E 30.2
12.58BTRY—
3.96BUSDP/E 33.6
loading…
Indicators:|
Key Statistics
Company
Market Cap273.62M USD
Enterprise Value308.50M USD
Revenue (TTM)232.40M USD
Gross Profit196.73M USD
Net Income (TTM)-5.34M USD
Revenue/Share0.8770 USD
Last Price1.020 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees194
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS00972D1054
Valuation
P/E (Trailing)—
P/E (Forward)-5.37
PEG—
EV/EBITDA25.43
EV/Revenue1.33
P/S1.18
P/B10.00
EPS (TTM)-0.08
EPS (Forward)-0.19
52W Range
0.990037% of range1.070
52W High1.070 USD
52W Low0.9900 USD
Profitability
Gross Margin83.29%
Oper. Margin-2.76%
EBITDA Margin5.22%
Profit Margin-2.26%
ROE-16.39%
ROA-1.42%
Growth
Revenue Growth-6.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF67.99M USD
CapEx (TTM)8.10M USD
FCF Margin28.32%
FCF Yield24.05%
Net Debt34.88M USD
Net Debt/EBITDA2.88
Balance Sheet
Debt/Equity1.59
Current Ratio1.40
Quick Ratio1.29
Book Value/Sh0.1020 USD
Cash/Share0.6060 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.2 (Strong Buy)
Target (Mean)4.200 USD
Target Range3.000 USD – 6.000 USD
# Analysts5
Ownership
Shares Out.268.26M
Float262.29M
Insiders4.00%
Institutions41.42%
Short Interest
Short Ratio12.3d
Short % Float10.45%
Short % Out.10.30%
Shares Short27.62M
Short (prev mo.)26.27M
Technical
SMA 501.346 (-24.2%)
SMA 2001.920 (-46.9%)
Beta0.35
S&P 52W Chg28.31%
Avg Vol (30d)5.53M
Avg Vol (10d)7.40M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—